HUMAN CHORIONIC BETA GONADOTROPIN (BHCG) - ANVISA Registration 80146501910

Access comprehensive regulatory information for HUMAN CHORIONIC BETA GONADOTROPIN (BHCG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146501910 and manufactured by ABBOTT POINT OF CARE INC. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including QUIBASA QUÍMICA BÁSICA LTDA, ABBOTT IRELAND DIAGNOSTICS DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80146501910
Registration Details
ANVISA Registration Number: 80146501910
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Família de controles: i-STAT Total b-hCG Control
Risk Class II

Registration Details

80146501910

25351637074201461

56998701000116

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Jan 19, 2015

VIGENTE

09/18/2025 19:00:01